HanchorBio signs licensing agreement with Shanghai Henlius Biotech to develop and commercialise rights to HCB101 across ...
HanchorBio Inc, a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, announced the signing of a major out-licensing agreement with Shanghai Henlius Biotech, Inc, a global …